Security key
00773U108
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)
CUSIP: 00773U108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 2,515,161
- Total 13F value
- $17,254,004
- Share change
- -1,069,245
- SEC-reported price per share
- $6.86
- Number of holders
- 2
- Value change
- -$15,119,117
- Number of sells
- 2
- Shares outstanding
- 22,163,711
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
2
Top holders
2
ADVM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Adverum Biotechnologies, Inc. SEC filings
Adverum Biotechnologies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00773U108
Recent filing periods:
Ownership snapshot
Top reported holders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TCG Crossover Management,...
Disclosed value leader
TCG Crossover Management,...
Comparable rows
3/11
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 9.1%
8 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
TCG Crossover Management, LLC leads the comparable SEC ownership view at 9.1%.
3 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TCG Crossover Management, LLC's linked filing trail.
Comparable ownership
Top 3
TCG Crossover Management, LLC
9.1%
Frazier Life Sciences Management,...
4.8%
Versant Venture Management, LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC |
13F
Company
|
9.1%
|
$28,397,928
2,008,340 shares
|
— | 31 Mar 2024 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
4.8%
|
$15,119,110
1,069,244 shares
|
— | 31 Mar 2024 |
| Versant Venture Management, LLC |
13F
Company
|
2.3%
|
$7,166,463
506,822 shares
|
— | 31 Mar 2024 |
| Julie Clark |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
$255,090
164,723 shares
|
— | 30 Sep 2021 |
| Angela Thedinga |
3/4/5
Chief Technology Officer
|
—
mixed-class rows
|
$232,290
270,000 shares
mixed-class rows
|
— | 06 Aug 2021 |
| Brigit Riley |
3/4/5
Chief Scientific Officer
|
—
class O/S missing
|
$181,860
117,435 shares
|
— | 15 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
2,515,161
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2024 holders
2
Holder diff
1
| Investor | Q3 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend